FDA Import Refusal 004-0177922-9/2/1 — GlaxoSmithKline Biologicals SA
The FDA refused shipment 004-0177922-9/2/1 from GlaxoSmithKline Biologicals SA (Belgium) on July 14, 2017. The refused product falls under Drugs and Biologics — MUMPS VIRUS VACCINE. Cited charge: 71 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- July 14, 2017
- Country
- Belgium
- Product Category
- Drugs and Biologics
- Product Code
- 57CI08 MUMPS VIRUS VACCINE
- Charges
- 71